Severe Aortic Thrombosis in the Early Period after COVID-19: Two Cases

Borulu, Ferhat; Erkut, Bilgehan

doi:10.1016/j.avsg.2021.01.057

Cited by 10 publications

(8 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 55 patients from the database research and 1 patient from our facility were included. 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Of the included studies, 12 were case series and 26 were case reports. Essential characteristics of the included patients are outlined in Table 2 .…”

Section: Resultsmentioning

confidence: 99%

Aortic Thrombosis following COVID-19: A Systematic Review

Petrov¹,

Romera²,

Wilbring³

et al. 2022

Thorac Cardiovasc Surg

View full text Add to dashboard Cite

Background Arterial and venous thromboses associated with the coronavirus disease 2019 (COVID-19) have been well described. These events are caused by a hypercoagulable state due to endotheliopathy and infection-driven coagulopathy. There has been an ever-increasing number of documented cases of aortic thrombosis (AoT) in COVID-19 patients. We conducted a systematic review of current scientific literature to identify and consolidate evidence of AoT in COVID-19 patients. Methods A systematic review of literature was conducted between March 15, 2020, and May 1, 2021, on PubMed and Cochrane databases. Additionally, a case from our facility was included. Results A total of 38 studies (12 case series and 26 case reports) and a case from our facility describing AoT in 56 COVID-19 patients were included. Patients were aged 64.8 ± 10.5 years, were predominantly male (75%), and had several comorbidities. AoT was symptomatic in 82,14% of patients; however, when D dimers were reported, they were significantly elevated even in otherwise asymptomatic patients. Most patients had no previous history of aortic disease. Thrombosis was described in all parts of the aorta, with several cases reporting multiple locations. The median reported time until development of AoT was 10 days. Peripheral thrombosis occurred in 73.21% of cases, most commonly causing lower limb ischemia. Mortality rate was 30.4%. Conclusions AoT can occur with no clinical symptoms or as a primary symptom in otherwise asymptomatic COVID-19 patients. D dimers are a highly sensitive diagnostic tool. Diagnosis of this condition prior to development of complications could be instrumental in saving many lives.

show abstract

Section: Resultsmentioning

confidence: 99%

Aortic Thrombosis following COVID-19: A Systematic Review

Petrov¹,

Romera²,

Wilbring³

et al. 2022

Thorac Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

“…The systematic review revealed thirty articles (17 case reports/series, 9 letters-to-journal-editors, 3 brief clinical imaging reports, and 1 retrospective study) detailing 52 SARS-CoV-2-positive patients with acute aortoiliac arterial thrombosis 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 . The available information from these cases were compiled and analyzed in addition to our institution's 7 cases.…”

Section: Resultsmentioning

confidence: 99%

Management of acute aortoiliac arterial thrombosis in patients with the novel coronavirus disease 2019: A case series and systematic review of the literature

Tohmasi

Kabutey

Maithel

et al. 2022

Annals of Vascular Surgery - Brief Reports and Innovations

View full text Add to dashboard Cite

“…Most publications have highlighted the frequency of venous thrombosis and pulmonary embolism complicating COVID-19. Arterial thromboembolic complications are less common [3,4].…”

Section: Discussionmentioning

confidence: 99%

Medium and large-sized arteries thrombosis in patients with COVID-19

Mabrouk¹

2022

J Clin Images Med Case Rep

View full text Add to dashboard Cite

Recent epidemiological studies have reported that hypercoagulopathy is a well-documented symptom of SARS-CoV-2 infection, particularly in more severe cases requiring admission to the critical care unit. We report here the clinical and imaging features of three patients with SARS-CoV-2 infection who developed acute thrombosis of the abdominal aorta, the superior mesenteric artery and cerebral arteries, respectively. The extensive manage of thrombo inflammation is necessary to enhance the outcome of this disease. It would be suitable to retain anticoagulant remedy after discharge, mainly in sufferers with severe disease and a poor prognosis.

show abstract

Severe Aortic Thrombosis in the Early Period after COVID-19: Two Cases

Cited by 10 publications

References 14 publications

Aortic Thrombosis following COVID-19: A Systematic Review

Aortic Thrombosis following COVID-19: A Systematic Review

Management of acute aortoiliac arterial thrombosis in patients with the novel coronavirus disease 2019: A case series and systematic review of the literature

Medium and large-sized arteries thrombosis in patients with COVID-19

Contact Info

Product

Resources

About